# Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients

> **NCT07064109** · NA · RECRUITING · sponsor: **Shanghai Tongji Hospital, Tongji University School of Medicine** · enrollment: 380 (estimated)

## Conditions studied

- ACS - Acute Coronary Syndrome

## Interventions

- **DRUG:** Colchicine 0.5 MG Oral Tablet Once Daily

## Key facts

- **NCT ID:** NCT07064109
- **Lead sponsor:** Shanghai Tongji Hospital, Tongji University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-07-01
- **Target enrollment:** 380 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07064109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07064109, "Multi-omics Characterization and Model Construction of Colchicine Anti-inflammatory Therapy Efficacy in ACS Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07064109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*